Icecure Medical Ltd. current report, Q3 FY2021

Business Context and Reporting Period

This Form 6-K filing by Icecure Medical Ltd. covers the month of August 2021, specifically dated August 26, 2021. The filing serves to report a material corporate event rather than providing periodic financial results.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of a corporate event and does not contain financial statements or performance metrics.

Material Changes

The primary material change reported is the commencement of trading for Icecure Medical Ltd. shares on the Nasdaq Capital Market, effective August 26, 2021.

Guidance, Outlook, and Risks

The filing does not contain management commentary, financial guidance, outlook, or a discussion of risks and contingencies. It solely references the press release regarding the Nasdaq listing.

Investor Verification Checklist

  • Verify the ticker symbol and trading status on the Nasdaq Capital Market.
  • Review the full text of the press release (Exhibit 99.1) for details on the listing.
  • Consult the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this filing contains none.